Inside Drug Pricing

Trump Again Demands Pharma CEOs Adopt Most Favored Nation Prices

By Maaisha Osman / July 31, 2025 at 6:32 PM

President Donald Trump on Thursday (July 31) sent letters to 17 pharmaceutical CEOs demanding they lower drug costs by extending “most favored nation” pricing to current Medicaid drugs and to newly launched products across Medicaid, Medicare, commercial plans and direct-to-consumer sales by Sept. 29.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

Trump Again Demands Pharma CEOs Adopt Most Favored Nation Prices

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.